Giorgia Guglielmi
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
Ethical, long-term partnerships can uncover valuable scientific insights while respecting Indigenous knowledge.
Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.
Environments and social factors shape human microbiotas.
The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.
The authors propose a coordinated framework involving policymakers, scientists, educators, and communities to embed microbiota science into One Health strategies.
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Dietary fiber during early life protects fertility by supporting healthy gut microbes and preventing ovarian damage caused by high-fat diets.
Gut microbes could be a target for preventing kidney disease-related heart failure.
Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.
